Wisconsin-based fusion technology company SHINE Technologies has signed a long-term supply agreement with Nucleus RadioPharma for the supply of lutetium-177, a radioisotope used in cancer treatment therapies, including those in development for the treatment of neuroendocrine tumors, prostate cancer, and other solid tumors.
Framatome, KHNP to investigate producing Lu-177 in South Korea
Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at...
Nonproliferation proponents call on Biden to oppose SHINE's proposed recycling plant
A group of 29 nonproliferation supporters sent a letter to President Biden asking that he withhold federal support for a proposed pilot plant for recycling spent nuclear fuel to be built by...
Orano, SHINE to cooperate on used fuel recycling plant
Orano and SHINE Technologies have agreed to cooperate in the development of a pilot plant capable of recycling used nuclear fuel from light water reactors on a commercial scale. In announcing...
Study indicates pilot facility could significantly reduce waste volumes
Waste disposal start-up Deep Isolation and fusion tech company SHINE Technologies have announced the completion of a collaborative study assessing the costs of disposing of radioactive...
Radioisotopes target cancer, improve imaging, and have myriad other medical uses
On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.That tiny amount of the...
The road to wellness: The task of getting lifesaving medical isotopes to patients
According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To ...
Germany’s ITM receives material license to produce Lu-177
Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the...
2024 GAIN vouchers will foster seven new advanced reactor technologies
The Gateway for Accelerated Innovation in Nuclear (GAIN) announced December 19 that seven firms will get vouchers to access the nuclear research facilities and expertise of the national...
Framatome to work with Romania’s Nuclearelectrica on Lu-177 production
Framatome and Nuclearelectrica, operator of Romania’s Cernavoda nuclear power plant, announced the signing of a memorandum of understanding to explore the possibility of producing the...
BWXT to supply Ac-225 generation to Fusion Pharmaceuticals
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials....